Medical Cyclotron Market Outlook to 2025, Key Product (10-12 MeV, 16-18 MeV, 19-24 MeV, 24 MeV & Above), Key Application (Neurosurgery, Oncology, Cardiology, & Clinical Research), End User (Hospitals, Diagnostic Centers and Research Institutes), Regional Segmentation, Pricing Analysis, Pipeline Analysis, Competitive Dynamics, M&A Insights, Regulatory Landscape, Segment Forecast and Conclusion

$3,650.00$6,650.00

Clear
  • Report Description
  • Table of Content
  • Highlight
  • Research Methodology
  • Request Free Sample

The Global medical cyclotron market was valued at $ 178.2 Million in 2017 and is forecast to grow at a modest xx.6 % CAGR between 2018 and 2025, culminating in 2025 global sales of $ 256.6 Million. Rising prevalence of chronic diseases, growing number of hospitals and ambulatory centers, increasing number of minimally invasive surgeries and technological advancement in medical cyclotron are some of the key drivers of this market.

 

We are observing steep rise in cases of chronic disease in last few years and trend is going to continue. Aging population and changing societal behavior adding to this steady increase. According to WHO chronic disease prevalence is expected to rise by 57%. This is going to increase medical diagnostic and imaging. Medical cyclotron is a machine used to make relatively short-lived radioisotopes that can be used for medical imaging purpose.

.

 

A chemical synthesis module is necessary to prepare radiopharmaceutical from the positron emitting radioisotopes produced in medical cyclotron. Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiopharmaceuticals, announced the arrival of a 70 MeV Cyclotron at its new production facility in Noblesville, Indiana.

.

 

Medical Cyclotron Market Outlook to 2025

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Global Medical Cyclotron Products”

 

Estimated Average Medical cyclotron product cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

Due to the wide array of products available in the market, pricing, positioning, and sales channel optimization play a vital role in the success of a product. On an average, in the Global, the medical cyclotron products are available at USD XXXX. However, the high-end products are available at much higher prices. The prices in emerging countries and developed countries vary significantly due to the difference in purchasing power and availability of latest products. The cost of a medical cyclotron facility would be very high. At current prices the capital cost might be expected to be in the range $6-10 Million with the annual operating costs of the order of $1 Million.

.

.

 

Product Insight

 

We have segmented the market based on the product types such as 10-12 MeV, 16-18 MeV, 19-24 MeV, 24 MeV & Above. The Cyclone 70P is an optimized, high-power proton cyclotron with variable proton acceleration in the energy range of 30 to 70 MeV. With cyclotron systems like the Eclipse cyclotron family to radiochemistry systems like Explora One, Siemens is innovating the future of biomarker production.

 

Application Insight

 

We have segmented the market based on applications as Neurosurgery, Oncology, Cardiology, & Clinical Research. We are observing increased usage in neurosurgery and cardiology. There are close to 1,218 cyclotrons installed worldwide to produce medical radionuclides.

A strong area of application of cyclotrons involves the production of short-lived neutron deficient radiotracers for use in emission tomography, especially positron emission tomography. This fast and quantitative in vivo diagnostic technique is being increasingly used in neurology, cardiology and oncology.

 

End-Use Insight

 

We have segmented the market based on end-user as hospitals, diagnostic centers and research institutes. We are observing major usage and increase in adaptation within hospital. Almost every leading cancer hospital having surgical unit is in the process of upgrading with latest medical cyclotron.

 

Technology Insight

 

Cyclotrons are most powerful particle accelerator technology until development of synchrotron and are used to produce particle beams in physics and nuclear medicine. The largest single-magnet cyclotron is built between 1940 and 1946 by Lawrence at the University of California at Berkeley, which could accelerate protons to 730 MeV. We have observed a larger medical cyclotron at the University of British Columbia in Vancouver, British Columbia which can produce 500 MeV protons.

 

Regional Segmentation

 

North America accounted for over xx% revenue share in 2017. The key reasons attributed for the high share include strong reimbursement framework, highly skilled medical professionals, technological advancements and government support for R&D and innovation in medical devices sector. Moreover, the presence of high-end hospital and high emphasis on surgeries is expected to boost the usage rates over the forecast period.

We have observed strong market during the years 2000-2007 with the development of the cyclotron networks for PET in USA and Western Europe and is expected to grow during the forecast period with rising demand from Asian and South American markets.

 

Merger and Acquisition Insight

 

We are observing some unique merger and acquisition in this space. ZEISS portfolio in surgical ophthalmology is get improved with acquisition of US-based manufacturer of Intraocular Lenses (IOLs) Aaren Scientific. Acquisition of Optronik AS in 2014 helps ZEISS to improve its positioning in the Turkish market. Alcon acquisition of WaveTec Vision helps to improve its ophthalmic surgical product portfolio.

 

Top Players & Company Share

 

We have profiled major players in the market as IBA; GE Healthcare; Siemens Medical Solutions USA, Inc.; Advanced Cyclotron Systems; Sumitomo Heavy Industries, Ltd.; and TeamBest (Best Medical International, Inc.). With recent development in technology, we are observing some unique new players into the market.

 

Market Segmentation

 

GLOBAL Medical Cyclotron Market by Product Types (Revenue, USD Million, 2014- 2025)

  • 10-12 MeV
  • 16-18 MeV
  • 19-24 MeV
  • 24 MeV & Above

GLOBAL Medical Cyclotron Market by Application (Revenue, USD Million, 2014 – 2025)

  • Neurosurgery
  • Oncology
  • Cardiology
  • Clinical Research

GLOBAL Medical Cyclotron Market by End-use (Revenue, USD Million, 2014- 2025)

  • Hospitals
  • Diagnostic Centers
  • Research Institutes

GLOBAL Medical Cyclotron Systems Regional Outlook (Revenue, USD Million, 2014- 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Columbia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Chapter 1 Methodology and Scope

  • Research Methodology
  • Research Scope & Assumptions
  • List of Data Sources

Chapter 2 Executive Summary

Chapter 3 Medical Cyclotron Market Overview

  • Disease Landscape
  • Healthcare Expenditure

Chapter 4 Medical Cyclotron Market Industry Outlook

  • Market Overview
  • Market Segmentation
  • Market Size and Growth Prospects
  • Leading Brand Dynamics
  • Major Buying Authorities and Decision-Making Process
  • Key Market Drivers
    • High prevalence of cancer
    • Cost advantage as a result of economy of scale in the number of nuclear medicine scans
    • Technological advancements in diagnosis and treatment of cancer
  • Key market restraint analysis
    • Stringent regulatory guidelines in installing cyclotron
    • High technical expertise required in operating radiological devices
  • Key Opportunities Prioritized
  • Company Market Share/Heat Map Analysis
  • Industry Analysis – Porter’s
  • Medical Cyclotron Market-PESTEL Analysis

Chapter 5: - Medical Cyclotron Market by “Product” (USD Million)

  • Medical Cyclotron Market Landscape by Product Type- 2014 & 2025
  • Cyclotron 10-12 MeV
  • Market Landscape Analysis, 2014-2025 (USD Mn)
  • Cyclotron 16-18 MeV
  • Market Landscape Analysis, 2014-2025 (USD Mn)
  • Cyclotron 19-24 MeV
  • Market Landscape Analysis, 2014-2025 (USD Mn)
  • Cyclotron 24 MeV
  • Market Landscape Analysis, 2014-2025 (USD Mn)
       

Chapter 6: Regional Segmentation Market Outlook

  • Medical Cyclotron Market Landscape by Region- 2017
  • North America Market Landscape Analysis, 2017-2025 (USD Mn)
    • U.S. Market Landscape Analysis, 2017-2025
    • Canada Market Landscape Analysis-2017-2025
  • Europe Market Landscape Analysis, 2017-2025 (USD Mn)
    • UK Market Landscape Analysis, 2017-2025
    • Germany Market Landscape Analysis, 2017-2025
    • France Market Landscape Analysis, 2017-2025
    • Italy Market Landscape Analysis, 2017-2025
    • Spain Market Landscape Analysis, 2017-2025
  • Latin America Market Landscape Analysis, 2017-2025 (USD Mn)
    • Brazil Market Landscape Analysis, 2017-2025
    • Mexico Market Landscape Analysis, 2017-2025
    • Colombia Market Landscape Analysis, 2017-2025
  • Asia pacific Market Landscape Analysis, 2017-2025 (USD Mn)
    • Japan Market Landscape Analysis, 2017-2025
    • China Market Landscape Analysis, 2017-2025
    • India Market Landscape Analysis, 2017-2025
  • Middle East & Africa Market Landscape Analysis, 2017-2025 (USD Mn)
    • Saudi Arabia Market Landscape Analysis, 2017-2025
    • South Africa Market Landscape Analysis, 2017-2025
 

Chapter 7: Pricing Analysis

 
  • Optimal Price Points (OPP), Indifference price points (IPP) and Range of Acceptable Prices and (RAP) of leading brands by Region- 2017
  • North America Pricing Analysis (OPP, IPP, and RAP - 2017)
    • U.S. Pricing Analysis-2017
    • Canada Pricing Analysis-2017
  • Europe Pricing Analysis (OPP, IPP, and RAP - 2017)
    • UK Pricing Analysis-2017
    • Germany Pricing Analysis-2017
    • France Pricing Analysis-2017
    • Italy Pricing Analysis-2017
    • Spain Pricing Analysis-2017
  • Latin America Pricing Analysis (OPP, IPP, and RAP - 2017)
    • Brazil Pricing Analysis-2017
    • Mexico Pricing Analysis-2017
    • Colombia Pricing Analysis-2017
  • Asia Pacific Pricing Analysis (OPP, IPP, and RAP - 2017)
    • Japan Pricing Analysis-2017
    • China Pricing Analysis-2017
    • India Pricing Analysis-2017
  • Middle East Pricing Analysis (OPP, IPP, and RAP - 2017)
    • Saudi Arabia Pricing Analysis-2017
    • South Africa Pricing Analysis-2017

Chapter 8: Medical Cyclotron Pipeline Analysis

  • Executive Summary
  • Late Stage Pipeline analysis
  • Key R&D trends

Chapter 9: Medical Cyclotron Market M&A Outlook

  • Major licensing deals
  • Factors driving M&A in Epigenetics market
  • Key trends and future outlook

Chapter 10: Medical Cyclotron Regulatory Landscape

  • Regulatory Landscape by Region (U.S., Europe, and Row)
  • Patent Landscape by Region (U.S., Europe, and Row)

Chapter 11: Competitive Dynamics

  • IBA
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • GE Healthcare
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Siemens Healthcare Limited
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  •   Advanced Cyclotron Systems.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  •   Sumitomo Heavy Industries, Ltd.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  •    Team Best.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
 

List of Tables

 
  • TABLE 1 Medical Cyclotron Market- Industry Snapshot & Key Buying Criteria, 2017 - 2025
  • TABLE 2 Global Epigenetics Market, 2017 – 2025
  • TABLE 3 Global Medical Cyclotron Market Analysis by Product-2017
  • TABLE 4 Global Medical Cyclotron Market Analysis by Technology -2017
  • TABLE 5 Global Medical Cyclotron Market Analysis by Application-2017
  • TABLE 7 Global Medical Cyclotron Market Analysis by Geography-2017
  • TABLE 8 Global Medical Cyclotron Market Analysis by Leading Brands-2017
  • TABLE 9 Medical Cyclotron Market- Key market driver analysis
  • TABLE 10 Medical Cyclotron Market- Key market restraint analysis
  • TABLE 11 North America Market Epigenetics Landscape Analysis, 2017-2025 (USD Mn)
  • TABLE 12U.S. Medical Cyclotron Market Landscape Analysis, 2017-2025
  • TABLE 13 Canada Medical Cyclotron Market Landscape Analysis, 201-2025
  • TABLE 14 Europe Medical Cyclotron Market Landscape Analysis, 2017-2025 (USD Mn)
  • TABLE 15 U.K Medical Cyclotron Market Landscape Analysis, 2017-2025
  • TABLE 16 Germany Medical Cyclotron Market Landscape Analysis, 2017-2025
  • TABLE 17 France Medical Cyclotron Market Landscape Analysis, 2017-2025
  • TABLE 18 Italy Medical Cyclotron Market Landscape Analysis, 2017-2025
  • TABLE 19 Spain Medical Cyclotron Market Landscape Analysis, 2017-2025
  • TABLE 20 Latin America Medical Cyclotron Market Landscape Analysis, 2017-2025 (USD Mn)
  • TABLE 21 Brazil Medical Cyclotron Market Landscape Analysis, 2017-2025
  • TABLE 22 Mexico Medical Cyclotron Market Landscape Analysis, 2017-2025
  • TABLE 20 Colombia Medical Cyclotron Market Landscape Analysis, 2017-2025
  • TABLE 21 Asia pacific Medical Cyclotron Market Landscape Analysis, 2017-2025 (USD Mn)
  • TABLE 22 Japan Medical Cyclotron Market Landscape Analysis, 2017-2025
  • TABLE 23 China Medical Cyclotron Market Landscape Analysis, 2017-2025
  • TABLE 24 India Medical Cyclotron Market Landscape Analysis, 2017-2025
  • TABLE 25 North America Pricing Analysis
  • TABLE 26 North America Pricing Analysis (OPP, IPP, and RAP- 2017)
  • TABLE 27 U.S. Pricing Analysis-2017
  • TABLE 28 Canada Pricing Analysis-2017
  • TABLE 29 Europe Pricing Analysis (OPP, IPP, and RAP- 2017)
  • TABLE 30 U.K Pricing Analysis-2017
  • TABLE 31 Germany Pricing Analysis-2017
  • TABLE 32 France Pricing Analysis-2017
  • TABLE 33 Italy Pricing Analysis-2017
  • TABLE 34 Spain Pricing Analysis-2017
  • TABLE 35 Latin America Pricing Analysis (OPP, IPP, and RAP- 2017)
  • TABLE 36 Brazil Pricing Analysis-2017
  • TABLE 37 Mexico Pricing Analysis-2017
  • TABLE 38 Colombia Pricing Analysis-2017
  • TABLE 39 Asia Pacific Pricing Analysis (OPP, IPP, and RAP- 2017)
  • TABLE 40 Japan Pricing Analysis-2017
  • TABLE 41 China Pricing Analysis-2017
  • TABLE 42 India Pricing Analysis-2017
  • TABLE 43 Middle East Pricing Analysis (OPP, IPP, and RAP- 2017)
  • TABLE 44 Saudi Arabia Pricing Analysis-2017
  • TABLE 45 South Africa Pricing Analysis-2017
 

List of Figures

 
  • 1 Medical Cyclotron Market Segmentation
  • 2 Market Size & Growth Prospects
  • 3 Leading Brand Dynamics
  • 4 Penetration & Growth Prospects
  • 5 Industry Analysis – Porter’s
  • 6 Medical Cyclotron Market– PESTEL Analysis
  • 7 Medical Cyclotron Market Share by Product Type, 2017 & 2025
  • 8 Medical Cyclotron Market Share by Technology Type, 2017 & 2025
  • 9 Medical Cyclotron Market Share by Application Type, 201 & 2025
  • 10 Medical Cyclotron Market Share by Region, 2017 & 2025
 

Key Insights Addressed:  

  • Defining market size from 2014 to 2017.
  • Estimating market growth till 2025 and consequence market forecast.
  • Identifying market drivers, restraints & future opportunities and allowing decision-maker with a range of possible outcomes and the probabilities that will occur for any choice of action.
  • Market segments and regions that will drive or lead market growth.
  • Defining Optimal Price Point (OPP) which will be accepted and recommended by maximum customers.
  • A bird’s-eye view of the competitive landscape and the key market players.
  • Key strategic growth driver adopted by market players. In-depth analysis of their strategies and implication on competition & growth.
    Key Findings:      
  • The Global medical cyclotron market was valued at $ 178.2 Million in 2017 and is forecast to grow at a modest xx.6 % CAGR between 2018 and 2025, culminating in 2025 global sales of $ 256.6 Million.
  • We are observing steep rise in cases of chronic disease in last few years and trend is going to continue. Aging population and changing societal behavior adding to this steady increase.
  • We have segmented the market based on the product types such as 10-12 MeV, 16-18 MeV, 19-24 MeV, 24 MeV & Above. The Cyclone 70P is an optimized, high-power proton cyclotron with variable proton acceleration in the energy range of 30 to 70 MeV
  • We have profiled major players in the market as IBA; GE Healthcare; Siemens Medical Solutions USA, Inc.; Advanced Cyclotron Systems; Sumitomo Heavy Industries, Ltd.; and TeamBest (Best Medical International, Inc.).

Ameri Research implies a unique methodology of published information and primary research to bring key insights to customer decision making process. Our analytics model helps us to understand the structured and unstructured information from various sources. Key steps involve in the process are as below-

  1. Analyzing Published Information- Access to large pool of paid and unpaid published information via different sources and analyzing market trend.
  2. Setting Foundation- Input from analysis of secondary sources set our foundation to market analysis and helps in setting the scope for further research. Setting the scope involves Ameri Research proprietary statistical model, discussion with industry leaders, internal brainstorming, key discussion pointers from various forums etc.
  3. Need Gap Analysis- Defining the gap between our scope and availability of information.
  4. KOL Panel Discussion- Focused Group Discussion with a structured discussion guide to fine tune the gap and deriving the factors driving/restraining the market trend.
  5. Quantitative Research- Sampling large number of industry players, Education/Research Institutes, Government bodies, NGOs, Individual acclaimed researchers and conducting the primary interview with a structured questionnaire.
  6. Data Triangulation- We apply bottom-up demand approach or top-down estimation or a combined approach to triangulate the data points.
  7. Analyst Comment- Each of our analysts carries large pool of experience from domain perspective and add their value which is directional in nature
global-aesthetic-dermatology-market

To request a free sample copy of this report, please complete the form below verified and secure

We offer complete free customization that addresses client’s need. This includes insights from primary market research and a 60-minute free analyst consultation post report purchase.

This website is secure and your personal details are safe. Privacy policy

Description

The Global medical cyclotron market was valued at $ 178.2 Million in 2017 and is forecast to grow at a modest xx.6 % CAGR between 2018 and 2025, culminating in 2025 global sales of $ 256.6 Million. Rising prevalence of chronic diseases, growing number of hospitals and ambulatory centers, increasing number of minimally invasive surgeries and technological advancement in medical cyclotron are some of the key drivers of this market.

 

We are observing steep rise in cases of chronic disease in last few years and trend is going to continue. Aging population and changing societal behavior adding to this steady increase. According to WHO chronic disease prevalence is expected to rise by 57%. This is going to increase medical diagnostic and imaging. Medical cyclotron is a machine used to make relatively short-lived radioisotopes that can be used for medical imaging purpose.

.

 

A chemical synthesis module is necessary to prepare radiopharmaceutical from the positron emitting radioisotopes produced in medical cyclotron. Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiopharmaceuticals, announced the arrival of a 70 MeV Cyclotron at its new production facility in Noblesville, Indiana.

.

 

Medical Cyclotron Market Outlook to 2025

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Global Medical Cyclotron Products”

 

Estimated Average Medical cyclotron product cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

Due to the wide array of products available in the market, pricing, positioning, and sales channel optimization play a vital role in the success of a product. On an average, in the Global, the medical cyclotron products are available at USD XXXX. However, the high-end products are available at much higher prices. The prices in emerging countries and developed countries vary significantly due to the difference in purchasing power and availability of latest products. The cost of a medical cyclotron facility would be very high. At current prices the capital cost might be expected to be in the range $6-10 Million with the annual operating costs of the order of $1 Million.

.

.

 

Product Insight

 

We have segmented the market based on the product types such as 10-12 MeV, 16-18 MeV, 19-24 MeV, 24 MeV & Above. The Cyclone 70P is an optimized, high-power proton cyclotron with variable proton acceleration in the energy range of 30 to 70 MeV. With cyclotron systems like the Eclipse cyclotron family to radiochemistry systems like Explora One, Siemens is innovating the future of biomarker production.

 

Application Insight

 

We have segmented the market based on applications as Neurosurgery, Oncology, Cardiology, & Clinical Research. We are observing increased usage in neurosurgery and cardiology. There are close to 1,218 cyclotrons installed worldwide to produce medical radionuclides.

A strong area of application of cyclotrons involves the production of short-lived neutron deficient radiotracers for use in emission tomography, especially positron emission tomography. This fast and quantitative in vivo diagnostic technique is being increasingly used in neurology, cardiology and oncology.

 

End-Use Insight

 

We have segmented the market based on end-user as hospitals, diagnostic centers and research institutes. We are observing major usage and increase in adaptation within hospital. Almost every leading cancer hospital having surgical unit is in the process of upgrading with latest medical cyclotron.

 

Technology Insight

 

Cyclotrons are most powerful particle accelerator technology until development of synchrotron and are used to produce particle beams in physics and nuclear medicine. The largest single-magnet cyclotron is built between 1940 and 1946 by Lawrence at the University of California at Berkeley, which could accelerate protons to 730 MeV. We have observed a larger medical cyclotron at the University of British Columbia in Vancouver, British Columbia which can produce 500 MeV protons.

 

Regional Segmentation

 

North America accounted for over xx% revenue share in 2017. The key reasons attributed for the high share include strong reimbursement framework, highly skilled medical professionals, technological advancements and government support for R&D and innovation in medical devices sector. Moreover, the presence of high-end hospital and high emphasis on surgeries is expected to boost the usage rates over the forecast period.

We have observed strong market during the years 2000-2007 with the development of the cyclotron networks for PET in USA and Western Europe and is expected to grow during the forecast period with rising demand from Asian and South American markets.

 

Merger and Acquisition Insight

 

We are observing some unique merger and acquisition in this space. ZEISS portfolio in surgical ophthalmology is get improved with acquisition of US-based manufacturer of Intraocular Lenses (IOLs) Aaren Scientific. Acquisition of Optronik AS in 2014 helps ZEISS to improve its positioning in the Turkish market. Alcon acquisition of WaveTec Vision helps to improve its ophthalmic surgical product portfolio.

 

Top Players & Company Share

 

We have profiled major players in the market as IBA; GE Healthcare; Siemens Medical Solutions USA, Inc.; Advanced Cyclotron Systems; Sumitomo Heavy Industries, Ltd.; and TeamBest (Best Medical International, Inc.). With recent development in technology, we are observing some unique new players into the market.

 

Market Segmentation

 

GLOBAL Medical Cyclotron Market by Product Types (Revenue, USD Million, 2014- 2025)

  • 10-12 MeV
  • 16-18 MeV
  • 19-24 MeV
  • 24 MeV & Above

GLOBAL Medical Cyclotron Market by Application (Revenue, USD Million, 2014 – 2025)

  • Neurosurgery
  • Oncology
  • Cardiology
  • Clinical Research

GLOBAL Medical Cyclotron Market by End-use (Revenue, USD Million, 2014- 2025)

  • Hospitals
  • Diagnostic Centers
  • Research Institutes

GLOBAL Medical Cyclotron Systems Regional Outlook (Revenue, USD Million, 2014- 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Columbia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Additional information

Price

Single User $3,650, Multiple User $4,650, Enterprise User $6,650